Skip Navigation



Mutagenesis Advance Access published online on April 5, 2006
Mutagenesis, doi:10.1093/mutage/gel019
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
21/3/185    most recent
gel019v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Smith, C. C.
Right arrow Articles by Martin, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, C. C.
Right arrow Articles by Martin, E. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the UK Environmental Mutagen Society. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org
Received January 26, 2006
Revised March 14, 2006
Accepted March 14, 2006

Original article

hOGG1 recognizes oxidative damage using the comet assay with greater specificity than FPG or ENDOIII

Catherine C. Smith 1, Michael R. O'Donovan 1, and Elizabeth A. Martin 1 *

1 Genetic Toxicology, Safety Assessment, AstraZeneca, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK

* To whom correspondence should be addressed.
Elizabeth A. Martin, E-mail: elizabeth.martin{at}astrazeneca.com


  Abstract

The European Standards Committee on Oxidative DNA Damage (ESCODD) recommended the use of the lesion-specific repair enzyme, formamidopyrimidine DNA-glycosylase (FPG) in the comet assay to detect oxidative DNA damage. In the present study, FPG was compared with endonuclease III (ENDOIII) and human 8-hydroxyguanine DNA-glycosylase (hOGG1) for the ability to modify the sensitivity of the comet assay. Mouse lymphoma L5178Y cells were treated with dimethyl sulphoxide (DMSO) as a standard solvent or reference agents known to induce oxidative damage (gamma irradiation and potassium bromate) or alkylation (methyl methanesulfonate, MMS; ethylnitrosurea, ENU). Using DMSO even up to toxic concentrations, no increase in breaks was seen with FPG, ENDOIII or hOGG1. With gamma irradiation (1-10 Gy), dose-related increases in breaks were seen with all three enzymes. FPG and hOGG1 gave similar increases in breaks after potassium bromate treatment between 0.25 and 2.5 mmol/l, but ENDOIII showed an increase only at the highest concentration, 2.5 mmol/l. Following MMS treatment (5-23 µmol/l), FPG induced a dramatic increase in breaks compared with control levels and ENDOIII also showed a significant but smaller increase; in marked contrast, hOGG1 gave no increase. With ENU (0.5-2.0 mmol/l), increases in breaks were seen with FPG and ENDOIII at 1 and 2 mmol/l but, again, no increase was observed with hOGG1. These data indicate that all three endonucleases recognize oxidative DNA damage and, in addition, FPG and ENDOIII also recognize alkylation damage. Therefore, caution should be taken when using FPG and ENDOIII in the comet assay with an agent that has an unknown mode of action since any additional strand breaks induced by either enzyme cannot necessarily be ascribed to oxidative damage. The use of hOGG1 in the modified comet assay offers a useful alternative to FPG and is apparently more specific for 8-oxoguanine and methyl-fapy-guanine.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
J.-H. Park, D. Mangal, A. J. Frey, R. G. Harvey, I. A. Blair, and T. M. Penning
Aryl Hydrocarbon Receptor Facilitates DNA Strand Breaks and 8-Oxo-2'-deoxyguanosine Formation by the Aldo-Keto Reductase Product Benzo[a]pyrene-7,8-dione
J. Biol. Chem., October 23, 2009; 284(43): 29725 - 29734.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. M. Westbrook, B. Wei, J. Braun, and R. H. Schiestl
Intestinal Mucosal Inflammation Leads to Systemic Genotoxicity in Mice
Cancer Res., June 1, 2009; 69(11): 4827 - 4834.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
R. G. Sturmey, C. P. Wild, and L. J. Hardie
Removal of red light minimizes methylene blue-stimulated DNA damage in oesophageal cells: implications for chromoendoscopy
Mutagenesis, May 1, 2009; 24(3): 253 - 258.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J.-H. Park, D. Mangal, K. A. Tacka, A. M. Quinn, R. G. Harvey, I. A. Blair, and T. M. Penning
Evidence for the aldo-keto reductase pathway of polycyclic aromatic trans-dihydrodiol activation in human lung A549 cells
PNAS, May 13, 2008; 105(19): 6846 - 6851.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
A. R. Collins, A. A. Oscoz, G. Brunborg, I. Gaivao, L. Giovannelli, M. Kruszewski, C. C. Smith, and R. Stetina
The comet assay: topical issues
Mutagenesis, May 1, 2008; 23(3): 143 - 151.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
M. Dusinska and A. R. Collins
The comet assay in human biomonitoring: gene-environment interactions
Mutagenesis, May 1, 2008; 23(3): 191 - 205.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
J. K. Folkmann, S. Loft, and P. Moller
Oxidatively damaged DNA in aging dyslipidemic ApoE-/- and wild-type mice
Mutagenesis, March 1, 2007; 22(2): 105 - 110.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.